Clinical trials for Genetic hemoglobinopathy
11 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT07087262A Phase I Study of SNH-119014 in Healthy VolunteersScinnoHub Pharmaceutical Co., Ltd.
- RECRUITINGN/ANCT06886477Sickle Cell, Pain and Mediterranean DietUniversity of Illinois at Chicago
- RECRUITINGPHASE1, PHASE2NCT06144749A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)Hillhurst Biopharmaceuticals, Inc.
- RECRUITINGN/ANCT07064941Effect of Exercise on Body Composition and Bone Health in Patients With ThalassemiaUniversity of California, San Francisco · PI: Ellen Fung, PhD
- ACTIVE NOT RECRUITINGN/ANCT06800495Development of THALEA Kit and Its Impact on Knowledge, Attitude, and Intention for Premarital Thalassemia ScreeningUniversiti Teknologi Mara
- ENROLLING BY INVITATIONNCT07003256Observational Study: Romiplostim for Platelet Recovery in Haploidentical HSCTHaikou Affiliated Hospital of Central South University Xiangya School of Medicine · PI: Xiaoyang Yang, MD
- RECRUITINGPHASE1, PHASE2NCT06481306A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseaseBristol-Myers Squibb · PI: Bristol-Myers Squibb
- RECRUITINGN/ANCT06031714Fetal Cell Receptors RepertoireAssistance Publique - Hôpitaux de Paris · PI: Sélim ARACTINGI, MD, PHD
- RECRUITINGNCT06071377Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)National Alliance for Sickle Cell Centers · PI: Julie Kanter, MD
- RECRUITINGPHASE1, PHASE2NCT05426252Thal-Fabs: Reduced Toxicity Conditioning for High Risk ThalassemiaThe Hospital for Sick Children · PI: Yogi Chopra, MD
- ACTIVE NOT RECRUITINGN/ANCT02286154Therapeutic Response Evaluation and Adherence Trial (TREAT)Children's Hospital Medical Center, Cincinnati · PI: Charles Quinn, MD, MS